$QNTA trading low volume compared to its 10-day av
Post# of 40201
![](/assets/46931549/no_avatar_available_thumb.jpg)
Confirmation of an FDA meeting to explore the possibility of a change from PIND to IND status and approving Escozine for a 30-to-60 patient pilot study to show proof of concept within the US would definitely help.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)